FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly psychiatry, and therapy efficiency forecast in schizophrenia cases by neuroleptic media such as haloperidol, olanzapine, risperidone, seroquel. Method involves electric encephalographic examination before therapy start, calculation of mean coherency (CmeanC) of frontal, central, parietal, femoral and temporal cortex lobes of brain, comparison to CmeanC of healthy test objects, and if CmeanC is reduced more than by 15% compared to healthy CmeanC then negative result of neuroleptic therapy is forecast.
EFFECT: extended range of methods for therapy efficiency forecast for this group of patients by proposed neuroleptic media.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARANOID SCHIZOPHRENIA AND SCHIZO-AFFECTIVE DISORDER | 2013 |
|
RU2532309C1 |
| METHOD OF DIAGNOSTICS OF SCHIZOPHRENIC DISORDER | 2017 |
|
RU2676657C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR PREDICTION OF THE PROBABILITY OF AN UNFAVORABLE OUTCOME IN RELATION TO THE SOCIAL POSTPSYCHOTIC FUNCTIONING OF THE PATIENTS WITH ENDOGENOUS PSYCHIC DISEASES | 2018 |
|
RU2706216C1 |
| METHOD FOR TREATING NEGATIVE DISORDERS IN CASE OF SCHISOPHRENIA | 2004 |
|
RU2266120C1 |
| METHOD FOR ESTIMATING REMISSION QUALITY IN PHENYLPROPANOLAMINE ADDICTION PATIENTS | 2006 |
|
RU2311871C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TRANSCRANIAL MAGNETIC STIMULATION OF BRAIN IN TREATING PATIENTS WITH DEPRESSIVE DISORDERS | 2019 |
|
RU2688338C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
